UNIVERSITY OF WASHINGTON
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Patient Self Monitoring of Physical Therapy Exercise
- Conditions
- Patellofemoral Syndrome
- Interventions
- Device: IBEHR
- First Posted Date
- 2013-02-01
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT01781325
- Locations
- πΊπΈ
University of Washington, Seattle, Washington, United States
Back Pain Outcomes Using Longitudinal Data (BOLD)
- Conditions
- Low Back Pain
- First Posted Date
- 2013-01-28
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 5239
- Registration Number
- NCT01776242
- Locations
- πΊπΈ
Harvard Vanguard Medical Associates, Boston, Massachusetts, United States
πΊπΈKaiser-Permanente of Northern California, Oakland, California, United States
πΊπΈHenry Ford Health System, Detroit, Michigan, United States
Structured Treatment of Pain (STOP) Study
- Conditions
- Chronic PainTraumatic Brain Injury
- Interventions
- Behavioral: Self-Management #2Behavioral: Self-Management #1
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 231
- Registration Number
- NCT01768650
- Locations
- πΊπΈ
Veteran Affairs Puget Sound Health Care System, Seattle, Seattle, Washington, United States
πΊπΈVA Puget Sound Health Care System, American Lake, Tacoma, Washington, United States
πΊπΈUniversity of Washington, Health Sciences Building, Seattle, Washington, United States
Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules
- Conditions
- Thyroid Nodule
- Interventions
- Device: SWUS Elastography
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 175
- Registration Number
- NCT01757834
- Locations
- πΊπΈ
University of Washington Medical Center, Seattle, Washington, United States
Fluoride Administered and Retained After Topical Fluoride Varnish
- Conditions
- Healthy
- Interventions
- Device: Fluoride varnish
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 6
- Registration Number
- NCT01754831
- Locations
- πΊπΈ
UW Center for Pediatric Dentistry, Seattle, Washington, United States
A Client-Based Outcome System for Individuals With Lower Limb Amputation
- Conditions
- Amputation
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 1572
- Registration Number
- NCT01750372
- Locations
- πΊπΈ
South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida, United States
πΊπΈUniversity of Washington, UWCORR, Seattle, Washington, United States
Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia
- Conditions
- Ventilator-acquired Pneumonia
- Interventions
- Device: PVC ETTDevice: PUC ETTDevice: PUC-CASS ETT
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2017-10-26
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 117
- Registration Number
- NCT01744483
- Locations
- πΊπΈ
Harborview Medical Center, Seattle, Washington, United States
Fecal Microbiota Transplantation for Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- Interventions
- Other: Fecal Microbiota Transplantation
- First Posted Date
- 2012-12-05
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 7
- Registration Number
- NCT01742754
- Locations
- πΊπΈ
University of Washington, Seattle, Washington, United States
Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer
- Conditions
- Stage IV Prostate CancerProstate AdenocarcinomaStage IIB Prostate CancerStage IIA Prostate CancerStage III Prostate Cancer
- Interventions
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 16
- Registration Number
- NCT01731912
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
- Conditions
- Stage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal CancerRecurrent Colon CarcinomaRecurrent Rectal Carcinoma
- Interventions
- Drug: CapecitabineDrug: CelecoxibRadiation: Intensity-Modulated Radiation TherapyOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentRadiation: Radiation TherapyRadiation: Stereotactic RadiosurgeryProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 27
- Registration Number
- NCT01729923
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States